Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
25M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
4.72M
-
Shares change
-
+2.49M
-
Total reported value, excl. options
-
$35.9M
-
Value change
-
+$19M
-
Number of buys
-
20
-
Number of sells
-
-4
-
Price
-
$7.61
Significant Holders of TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) as of Q3 2025
35 filings reported holding TENX - TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2025.
TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.72M shares
of 25M outstanding shares and own 18.92% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (968K shares), VR ADVISER, LLC (438K shares), RTW INVESTMENTS, LP (378K shares), Siren, L.L.C. (352K shares), BOOTHBAY FUND MANAGEMENT, LLC (352K shares), BVF INC/IL (340K shares), MILLENNIUM MANAGEMENT LLC (314K shares), Vivo Capital, LLC (208K shares), MORGAN STANLEY (178K shares), and MARSHALL WACE, LLP (177K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.